hotspot
Previous article:
Apple is now the first public company to be valued at $3 trillion
Next article: Sarepta Duchenne therapy fails to meet primary endpoint in trial
Next article: Sarepta Duchenne therapy fails to meet primary endpoint in trial
focus
explore
-
Listen: A conversation with researcher Kevin Esvelt on biosecurity
2025-10-02 12:09 -
Scrutiny of post
2025-10-02 11:32 -
Liver decline slowed by off
2025-10-02 11:26 -
UnitedHealth argues against case alleging wrongful AI care denials
2025-10-02 11:12 -
Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again
2025-10-02 10:57 -
After Sarepta trial failure, Duchenne families brace for more debate
2025-10-02 10:36